Pharmaceuticals, Biotech and Chemicals sector: performance, industries and movers
Updated 30 October 2026, 21:45 ET
The Pharmaceuticals, Biotech and Chemicals sector covers 609 companies in FundSpec's universe. Its average member is up 2.0% over one day, up 6.2% over 30 days and down 92.1% over one year. Figures as of the close on 29 October 2026.
Performance by horizon
1 day+2.04%
5 days+1.52%
30 days+6.25%
180 days+3.85%
1 year-92.12%
A sector move is the average percentage change of its member stocks over the horizon, so a few large moves in small companies can lift or sink it. Compare the 30-day and one-year columns to separate a rotation from a trend. Read the guide: Sector rotation and sector performance.
The interactive view with every horizon and industry is in Sector Performance.
Industries
Industries within the sector ranked by their 30-day move:
| Industry | Members | 30 days |
|---|---|---|
| Biological Products, (No Diagnostic Substances) | 115 companies | +13.13% |
| Perfumes, Cosmetics & Other Toilet Preparations | 8 companies | +10.27% |
| Industrial Inorganic Chemicals | 10 companies | +9.17% |
| In Vitro & In Vivo Diagnostic Substances | 12 companies | +9.00% |
| Pharmaceutical Preparations | 326 companies | +6.53% |
| Medicinal Chemicals & Botanical Products | 10 companies | +4.71% |
| Pharmaceuticals, Biotech and Chemicals | 72 companies | +2.42% |
| Miscellaneous Chemical Products | 7 companies | +2.25% |
| Plastic Materials, Synth Resins & Nonvulcan Elastomers | 9 companies | +1.90% |
| Industrial Organic Chemicals | 19 companies | +0.21% |
| Chemicals & Allied Products | 11 companies | -5.04% |
| Agricultural Chemicals | 10 companies | -13.61% |
Movers, 30 days
Strongest over 30 days
| Ticker | Company | Industry | 30 days |
|---|---|---|---|
| KOD | Kodiak Sciences Inc. | Biological Products, (No Diagnostic Substances) | +205.63% |
| PDSB | PDS Biotechnology Corp | Pharmaceutical Preparations | +84.04% |
| SRZN | Surrozen, Inc. | Biological Products, (No Diagnostic Substances) | +73.91% |
| GMAB | Genmab A/S | Pharmaceuticals, Biotech and Chemicals | +63.57% |
| DNA | Ginkgo Bioworks Holdings, Inc. | Biological Products, (No Diagnostic Substances) | +62.50% |
| MYGN | Myriad Genetics Inc | In Vitro & In Vivo Diagnostic Substances | +61.11% |
| BHC | Bausch Health Companies Inc. | Pharmaceutical Preparations | +57.70% |
| SLN | Silence Therapeutics plc | Pharmaceutical Preparations | +55.91% |
| PCRX | Pacira BioSciences, Inc. | Pharmaceutical Preparations | +48.65% |
| MRNA | Moderna, Inc. | Biological Products, (No Diagnostic Substances) | +40.92% |
Weakest over 30 days
| Ticker | Company | Industry | 30 days |
|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | -59.12% |
| AVTX | Avalo Therapeutics, Inc. | Pharmaceutical Preparations | -55.42% |
| FMC | FMC Corp | Chemicals & Allied Products | -53.01% |
| FHTX | Foghorn Therapeutics Inc. | Pharmaceutical Preparations | -50.24% |
| AVXL | Anavex Life Sciences Corp. | Biological Products, (No Diagnostic Substances) | -46.06% |
| PYXS | Pyxis Oncology, Inc. | Pharmaceutical Preparations | -44.57% |
| CUE | Cue Biopharma, Inc. | Pharmaceutical Preparations | -43.31% |
| NKTR | Nektar Therapeutics | Pharmaceutical Preparations | -42.69% |
| QURE | uniQure N.V. | Pharmaceutical Preparations | -42.62% |
| MGNX | MacroGenics Inc | Pharmaceutical Preparations | -42.37% |
Movers, 1 day
Strongest over 1 day
| Ticker | Company | Industry | 1 day |
|---|---|---|---|
| BHC | Bausch Health Companies Inc. | Pharmaceutical Preparations | +28.76% |
| MESO | Mesoblast Ltd | Biological Products, (No Diagnostic Substances) | +17.03% |
| INSM | Insmed Inc | Pharmaceutical Preparations | +15.06% |
| ELDN | Eledon Pharmaceuticals, Inc. | Pharmaceutical Preparations | +10.14% |
| PGEN | Precigen, Inc. | Pharmaceutical Preparations | +9.21% |
| REPL | Replimune Group, Inc. | Biological Products, (No Diagnostic Substances) | +8.28% |
| LXU | LSB Industries, Inc. | Industrial Inorganic Chemicals | +8.07% |
| LLY | Eli Lilly & Co | Pharmaceutical Preparations | +6.63% |
| CAPR | Capricor Therapeutics, Inc. | Pharmaceutical Preparations | +6.42% |
| FMC | FMC Corp | Chemicals & Allied Products | +6.26% |
Weakest over 1 day
| Ticker | Company | Industry | 1 day |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | Biological Products, (No Diagnostic Substances) | -35.45% |
| ALNY | Alnylam Pharmaceuticals, Inc. | Pharmaceutical Preparations | -25.13% |
| CHRS | Coherus Oncology, Inc. | Biological Products, (No Diagnostic Substances) | -22.55% |
| HLN | Haleon plc | Pharmaceuticals, Biotech and Chemicals | -14.30% |
| OTLK | Outlook Therapeutics, Inc. | Biological Products, (No Diagnostic Substances) | -9.43% |
| TRDA | Entrada Therapeutics, Inc. | Pharmaceutical Preparations | -9.09% |
| NEU | NewMarket Corp | Industrial Organic Chemicals | -8.04% |
| ADCT | ADC Therapeutics SA | Pharmaceutical Preparations | -8.02% |
| CLLS | Cellectis S.A. | Biological Products, (No Diagnostic Substances) | -7.14% |
| CRMD | CorMedix Inc. | Pharmaceutical Preparations | -6.83% |
Covered companies
Members with a FundSpec stock page, by market capitalization:
| Ticker | Company | Last close | Day | 30 days |
|---|---|---|---|---|
| LLY | Eli Lilly & Co. | $1,417.54 | +3.19% | +19.20% |
| JNJ | Johnson & Johnson | $273.20 | -0.73% | +1.84% |
| ABBV | AbbVie Inc. | $294.89 | +1.41% | +10.14% |
| PG | Procter & Gamble Co. | $161.57 | +0.61% | +8.84% |
| MRK | Merck & Co. Inc. | $149.52 | +2.18% | -0.56% |
| NVS | Novartis AG | $160.79 | -0.19% | +14.32% |
| AZN | AstraZeneca PLC | $186.65 | +7.02% | +4.97% |
| AMGN | Amgen Inc. | $466.01 | +1.15% | +21.31% |
| LIN | Linde PLC | $514.24 | +2.20% | +9.74% |
| GILD | Gilead Sciences, Inc. | $170.68 | +3.06% | +9.76% |
| ABT | Abbott Laboratories | $106.20 | +1.56% | +2.29% |
| PFE | Pfizer Inc. | $30.52 | +1.90% | +8.36% |
| NVO | Novo Nordisk A S | $40.00 | +2.20% | -9.38% |
| UL | Unilever PLC | $65.26 | +1.68% | +3.15% |
| VRTX | Vertex Pharmaceuticals Inc. | $558.88 | +3.50% | +4.58% |
| BMY | Bristol Myers Squibb Co. | $62.48 | +1.78% | -2.31% |
| SNY | Sanofi | $44.34 | +2.81% | -0.02% |
| GSK | GSK plc | $49.51 | +1.71% | -4.66% |
| MRNA | Moderna, Inc. | $221.72 | -0.47% | +40.92% |
| ECL | Ecolab Inc. | $302.98 | +0.70% | +10.74% |
| REGN | Regeneron Pharmaceuticals, Inc. | $927.89 | +13.33% | +3.71% |
| CL | Colgate Palmolive Co. | $95.29 | +2.29% | +6.19% |
| APD | Air Products & Chemicals, Inc. | $316.43 | +1.50% | +8.96% |
| TAK | Takeda Pharmaceutical Co. Ltd. | $20.91 | +4.50% | +5.04% |
| ARGX | argenx SE | $892.87 | -0.55% | -9.83% |
| TEVA | Teva Pharmaceutical Industries Ltd. | $42.09 | +1.50% | +5.82% |
| IDXX | IDEXX Laboratories Inc. | $551.21 | -4.30% | +13.72% |
| HLN | Haleon plc | $8.66 | +1.05% | -8.44% |
| RVMD | Revolution Medicines, Inc. | $191.31 | +0.55% | -3.39% |
| EL | Estee Lauder Companies Inc. | $109.23 | +0.39% | +15.93% |
| RPRX | Royalty Pharma plc | $67.18 | +1.90% | +11.88% |
| BIIB | Biogen Inc. | $253.62 | +1.59% | +13.97% |
| GMAB | Genmab A/S | $57.06 | +1.01% | +63.57% |
| NTR | Nutrien Ltd. | $69.42 | +1.37% | -13.23% |
| ZTS | Zoetis Inc. | $79.72 | +1.17% | +7.92% |
| PPG | PPG Industries Inc. | $119.52 | -0.40% | +13.80% |
| CHD | Church & Dwight Co. Inc. | $107.23 | +1.16% | +11.52% |
| DOW | Dow Inc. | $34.70 | +3.21% | +14.00% |
| IFF | International Flavors & Fragrances Inc. | $93.02 | +2.43% | +6.95% |
| VTRS | Viatris Inc. | $19.04 | -0.86% | +12.08% |
| LYB | LyondellBasell Industries N.V. | $68.64 | +5.00% | +1.74% |
| DD | DuPont de Nemours, Inc. | $140.05 | -0.38% | +9.43% |
| CF | CF Industries Holdings, Inc. | $123.30 | +4.41% | -11.75% |
| TECH | Bio-Techne Corp. | $72.66 | -0.07% | +0.41% |
| ALB | Albemarle Corp. | $91.00 | -2.43% | -18.93% |
| CLX | Clorox Co. | $88.00 | -0.76% | +4.32% |
| MOS | Mosaic Co. | $18.39 | +0.88% | -28.20% |